Women Nearing Menopause Might Track Down Bone Loss Earlier

A new study could help physicians determine when, and how, to treat bone loss in women as they near menopause before that bone loss causes significant health issues.

Physicians may be able to determine if menopause-related bone loss is already in progress or about to begin by measuring the level of a hormone that declines as women approach their final menstrual period, finds new UCLA research.

The findings are published in the peer-reviewed Journal of Bone and Mineral Research.

Perimenopause - Causes, Symptoms, Diagnosis and Treatment
Perimenopause is a transition phase that lasts until menopause. The low estrogen levels during this phase cause irregular periods and early menopause symptoms such as hot flashes. This phase may last from a few months to years.

‘Women nearing menopause can use the levels of the anti-Mullerian hormone, or AMH to determine if they are experiencing, or about to experience bone loss.’

“To be able to intervene and reduce the rate and amount of bone loss, we need to know if this loss is imminent or already ongoing,” said the study’s lead author, Dr. Arun Karlamangla, a professor of medicine in the division of geriatrics at the David Geffen School of Medicine at UCLA.

Women experience significant bone loss during the menopause transition, a roughly three-year window that brackets the final menstrual period and is accompanied by other symptoms such as irregular menstrual cycles, hot flashes, and mood and sleep disorders. Levels of the AMH decline as a woman’s final menstrual period draws closer.

To explore more, researchers examined data from the Study of Women’s Health Across the Nation, or SWAN, a multisite, multi-ethnic study examining the changes women undergo during the transition to menopause.

Hormone Replacement Therapy
Hormone Replacement Therapy can be likened to an ‘oasis in the desert’ for women in the throes of menopause.

They found that 17% of premenopausal women age 42 or older will have lost a significant fraction of their peak bone mass within two to three years of the date a physician makes the prediction.

But among those with less than 50 picograms of AMH per milliliter of blood, nearly double the percentage, 33%, will have lost a significant fraction of peak bone mass in the same timeframe.

Can Menopause At An Early Age Bring You Coronary Heart Disease?
Early onset of menopause (before age 40) could make women vulnerable to developing coronary heart disease throughout their lifetime.

In addition, women in early perimenopause (meaning that they have irregular menstrual bleeding but with no more than a three-month gap between periods) will have lost a significant fraction of peak bone mass within two to three years.

But among women in early perimenopause with AMH levels below 25 pg/mL, 65% will have lost a significant percentage of peak bone mass in that time.

Quiz on Perimenopause
Perimenopause, also called menopause transition, begins a few months or years before the actual menopause. This is the period of natural transition of a woman towards infertility and menopause. Here is a quiz on this time of a woman’s life:

The findings cannot be applied to women who are already taking osteoporosis medications, have undergone a hysterectomy before their final period, or have used exogenous sex hormones during the transition to menopause.

However, these findings make feasible the designing and testing of midlife interventions to prevent or delay osteoporosis in women.

Source-Medindia